Pfizer stops work on oral GLP-1 obesity drug

The latest stories trending on MedCity News.

Editor's Pick

Top Story Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial Pfizer said a patient dosed with danuglipron developed potential drug-induced liver injury. Pfizer is stopping further work on this program, a move that comes nearly two years after it discontinued development of a different obesity drug due to liver safety signals in a clinical trial. Sponsored Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options Presented by FASERNA FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.  Learn more. Bobby Reddy, Jr. CEO & Co-Founder at Prenosis, Inc. will be Speaking at INVEST 2025 Bobby will be part of the panel, "How is AI Reshaping the Life Sciences?" AI is not just about boosting hospital operational efficiency or radiological capability. It is reshaping other parts of the healthcare industry be it in pharma or medical devices. Hear from healthcare leaders about how AI can have an impact on everything from clinical trials, disease management to drug development. Secure Your Seat & Save $300 Now

Featured News

How One Startup Is Making Egg Freezing More Affordable and Equitable Cofertility raised $7.25 million in Series A funds, taking its total funding to date to $16 million. The startup is making egg freezing more accessible by tying it to egg donation — it offers one program in which women can pay to freeze their eggs and store them all for their own later use, and another one that allows women to freeze their eggs for free when they give half to a family who can't otherwise conceive. JPMorgan: How Small and Mid-Sized Businesses Make Healthcare Decisions About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from JPMorganChase Institute shows. How Technology and Value-Based Models Will Reshape Healthcare by 2035 The decade ahead will test our healthcare system like never before. But within these challenges lies an opportunity to create a more accessible, effective, and sustainable healthcare system — if we dare to innovate and adapt to the changing landscape. Medication Adherence and Deprescribing Programs Aren't Enough for Today's Polypharmacy Patients By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used — not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health.

Video   House passes GOP budget plan The House passed the GOP's budget plan, which seeks to slash Medicaid funding by billions. The House had originally passed the legislation in February, but the Senate introduced a revised version afterwards. The news comes the same week as Fabrizio Ward, the firm that conducted polls for President Donald Trump's 2024 campaign, released research showing that Medicaid cuts are unpopular among most Trump voters.

Sponsored What Are the Best Medical Coding Outsourcing Companies? Presented by Global Healthcare Resource Outsourcing your medical coding can help ensure a healthy revenue cycle. Discover the best medical coding outsourcing companies and find the right one for you. Learn More

Resources

Pivot: Discussing the Impact of a Proposed HIPAA Security Update All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA tackling data encryption. Bryan Marlatt, chief regional officer at CyXcel, talks with us about the evolving threat landscape and what the proposed rule means for healthcare organizations. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe